Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients

Eur J Cardiothorac Surg. 1991;5(4):205-10. doi: 10.1016/1010-7940(91)90031-e.

Abstract

We determined the time-course of the release of atrial natriuretic factor (ANF) during cardiopulmonary bypass (CPB) in six patients undergoing coronary artery bypass (CAD) and eight patients undergoing valve replacement for mitral stenosis (MS). Before CPB, the arterial ANF was significantly higher in MS patients than in CAD patients (243 +/- 38 and 29 +/- 5.8 pg/ml respectively, P less than 0.01). With the onset of CPB, the acute pressure unloading of the atria induced a significant, rapid decrease of ANF only in MS patients (-64% of pre-CPB value at 5 min) and no major changes in CAD patients. Clamping of the aorta induced a further progressive reduction of ANF release to almost zero in both groups. Readmission of coronary flow to the empty atria with declamping resulted in an increase in the plasma level of ANF in both groups to reach the concentration present in MS patients before CPB. After CPB, the ANF levels decreased in CAD patients while remaining elevated in MS patients. These data suggest that ANF release from human atria depends on atrial filling pressure and other unknown factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Atrial Natriuretic Factor / blood*
  • Cardiopulmonary Bypass*
  • Coronary Disease / blood
  • Coronary Disease / surgery*
  • Female
  • Heart Valve Prosthesis*
  • Hemodynamics / physiology
  • Humans
  • Intraoperative Complications / blood*
  • Male
  • Middle Aged
  • Mitral Valve Stenosis / blood
  • Mitral Valve Stenosis / surgery*
  • Myocardial Reperfusion Injury / blood
  • Postoperative Complications / blood
  • Reference Values
  • Saphenous Vein / transplantation

Substances

  • NPPA protein, human
  • Atrial Natriuretic Factor